Details for Patent: 9,439,902
✉ Email this page to a colleague
Title: | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
Abstract: | Compounds of Formula (A) and (B) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors). ##STR00001## |
Inventor(s): | Mascitti; Vincent (Groton, CT) |
Assignee: | Pfizer Inc. (New York, NY) |
Filing Date: | Nov 07, 2014 |
Application Number: | 14/535,613 |
Claims: | 1. A method for treating obesity in humans comprising the step of administering to a human in need of such treatment a therapeutically effective amount of a pharmaceutical composition comprising: (i) (1S,2S,3S,4R,5S)-5-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl-- 6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol; (ii) a pharmaceutically acceptable excipient, diluent, or carrier and (iii) metformin; or a pharmaceutically acceptable salt thereof. 2. A method for treating Type 2 diabetes in humans comprising the step of administering to a human in need of such treatment a therapeutically effective amount of a pharmaceutical composition comprising: (i) (1 S ,2S ,3S,4 R,5S)-5-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl-6,8-d- ioxa-bicyclo[3.2.1]octane-2,3,4-triol; (ii) a pharmaceutically acceptable excipient, diluent, or carrier and (iii) metformin; or a pharmaceutically acceptable salt thereof. |